Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03515993 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Follow-up in Gynecological Cancer Survivors

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Aug 31, 2026 → Dec 31, 2026
See other at-risk trials from European Organisation for Research and Treatment of Cancer - EORTC

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 31, 2026 to Dec 31, 2026
    • Eligibility criteria expanded, about 11 words
    • Site details revised at 2 of 21 sites
  2. Primary completion date: Mar 31, 2024 to Aug 31, 2026
    • Study completion date: Apr 30, 2024 to Aug 31, 2026
    v20
  3. Primary completion date: Dec 31, 2023 to Mar 31, 2024
    • Study completion date: Dec 31, 2023 to Apr 30, 2024
    v19
  4. Primary and study completion dates: Jun 2023 to Dec 31, 2023v18
  5. Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: Feb 2023 to Jun 2023
    • Site details revised at 21 of 21 sites
    v17
Show 15 earlier versionsHide 15 earlier versions
  1. Primary and study completion dates: Dec 2022 to Feb 2023v16
  2. Study sites: 20 to 21v15
  3. Primary and study completion dates: Dec 2021 to Dec 2022v14
  4. Re-verified, no change to tracked fieldsv13
  5. Study sites: 19 to 20v12
  6. Study sites: 18 to 19v11
  7. Study sites: 16 to 18v10
  8. Primary and study completion dates: Dec 2020 to Dec 2021
    • Study sites: 11 to 16
    v9
  9. Primary and study completion dates: Feb 2020 to Dec 2020
    • Study sites: 9 to 11
    v8
  10. Study sites: 7 to 9v7
  11. Study sites: 6 to 7v6
  12. Study sites: 4 to 6v5
  13. Study sites: 2 to 4v4
  14. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Primary and study completion dates: Dec 2019 to Feb 2020
    • Start date changed from estimate of Feb 2019 to Feb 21, 2019
    v3
  15. Start date: Jun 2018 to Feb 2019v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A cross-sectional prospective study of follow-up in gynecologic cancer patients after primary treatment
Trial Details
NCT Number NCT03515993
Lead Sponsor European Organisation for Research and Treatment of Cancer - EORTC
Conditions
(from sponsor)		 Gynecologic Cancer
Enrollment 1,100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov